Cayenne Medical Inc., a Scottsdale, Ariz.-based sports medicine company focused on soft tissue reconstruction, has raised $15 million in Series C funding. Investor Growth Capital led the round, and was joined by return backer Split Rock Partners. The company had previously raised $13.8 million.
Cayenne Medical, Inc., a privately held sports medicine company based in Scottsdale, Arizona announced today that it has closed a $15 million Series C financing led by Investor Growth Capital (“IGC“). Other participating investors include SplitRock Partners, MB Venture Partners and a group of accredited private individuals. Stephen M. Campe, Managing Director of IGC, has joined Cayenne's Board in connection with the financing. This financing round brings Cayenne's total private equity investment to $32 million.
Cayenne's lead product, the AperFix